Cyclin K and cyclin D1b are oncogenic in myeloma cells

BackgroundAberrant expression of cyclin D1 is a common feature in multiple myeloma (MM) and always associated with mantle cell lymphoma (MCL). CCND1 gene is alternatively spliced to produce two cyclin D1 mRNA isoforms which are translated in two proteins: cyclin D1a and cyclin D1b. Both isoforms are present in MM cell lines and primary cells but their relative role in the tumorigenic process is still elusive.ResultsTo test the tumorigenic potential of cyclin D1b in vivo, we generated cell clones derived from the non-CCND1 expressing MM LP-1 cell line, synthesizing either cyclin D1b or cyclin K, a structural homolog and viral oncogenic form of cyclin D1a. Immunocompromised mice injected s.c. with LP-1K or LP-1D1b cells develop tumors at the site of injection. Genome-wide analysis of LP-1-derived cells indicated that several cellular processes were altered by cyclin D1b and/or cyclin K expression such as cell metabolism, signal transduction, regulation of transcription and translation. Importantly, cyclin K and cyclin D1b have no major action on cell cycle or apoptosis regulatory genes. Moreover, they impact differently cell functions. Cyclin K-expressing cells have lost their migration properties and display enhanced clonogenic capacities. Cyclin D1b promotes tumorigenesis through the stimulation of angiogenesis.ConclusionsOur study indicates that cyclin D1b participates into MM pathogenesis via previously unrevealed actions.

[1]  J. Herman,et al.  Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 , 2006, Oncogene.

[2]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[3]  J. Cigudosa,et al.  Cyclin D1 gene (CCND1) mutations in endometrial cancer , 2003, Oncogene.

[4]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[5]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[6]  H. Rui,et al.  Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome , 2009, Oncogene.

[7]  M. Lisanti,et al.  Cyclin D1 induction of cellular migration requires p27(KIP1). , 2006, Cancer research.

[8]  J. Diehl,et al.  An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. , 2003, Cancer research.

[9]  M. Monden,et al.  Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization , 2006, Clinical Cancer Research.

[10]  G. Prendergast,et al.  Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration* , 2008, Journal of Biological Chemistry.

[11]  P. Nowell,et al.  Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. , 2006, Blood.

[12]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[13]  B. Zhivotovsky,et al.  Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.

[14]  B. Sola,et al.  Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. , 2007, Experimental cell research.

[15]  M. Wasik,et al.  Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma , 2006, Oncogene.

[16]  A. Senderowicz,et al.  Cyclin D1 Splice Variants , 2003, Journal of Biological Chemistry.

[17]  C. Bassing,et al.  Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis , 2007, Oncogene.

[18]  Kenneth C. Anderson,et al.  Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets , 2007, Nature Reviews Cancer.

[19]  J. Gray,et al.  The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis , 2004, Cancer Research.

[20]  L. Staudt,et al.  Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. , 2004, Cancer cell.

[21]  Gonzalez,et al.  Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. , 2003, Blood.

[22]  O. Delattre,et al.  Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer , 2008, Proceedings of the National Academy of Sciences.

[23]  B. Sola,et al.  Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma , 2006, BMC Cancer.

[24]  J L Cleveland,et al.  Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. , 2000, Genes & development.

[25]  H. Rui,et al.  Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. , 2008, Cancer research.

[26]  H. Kiyokawa,et al.  Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation , 2008, Nature.

[27]  Tom C. Freeman,et al.  An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes , 2006, Nucleic acids research.

[28]  Y. Yuzawa,et al.  A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics , 2004, Cancer Research.

[29]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[30]  Anping Li,et al.  Cyclin D1 Determines Mitochondrial Function InVivo , 2006, Molecular and Cellular Biology.

[31]  Chenguang Wang,et al.  Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Leonhard Müllauer,et al.  Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. , 2008, Cancer research.

[33]  A. Bikfalvi,et al.  Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. , 2002, Cancer research.

[34]  P. L. Bergsagel,et al.  Molecular pathogenesis and a consequent classification of multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  J. D. Vos,et al.  Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays , 2002, Oncogene.

[36]  N Thatcher,et al.  Alternate splicing produces a novel cyclin D1 transcript. , 1995, Oncogene.

[37]  P. Ojala,et al.  Cell signaling pathways engaged by KSHV. , 2006, Biochimica et biophysica acta.

[38]  D. Carrasco,et al.  Identification of genes modulated in multiple myeloma using genetically identical twin samples. , 2004, Blood.

[39]  H. Lovec,et al.  Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.

[40]  T. Rème,et al.  Induction of angiogenesis by normal and malignant plasma cells. , 2009, Blood.

[41]  O. Coqueret,et al.  Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. , 2003, Blood.

[42]  E. Campo,et al.  Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.

[43]  M. Yaniv,et al.  The human SWI/SNF subunit Brm is a regulator of alternative splicing , 2006, Nature Structural &Molecular Biology.

[44]  J. Woodgett,et al.  A molecular compendium of genes expressed in multiple myeloma. , 2002, Blood.

[45]  J. Heighway,et al.  Induced expression of human CCND1 alternative transcripts in mouse Cyl‐1 knockout fibroblasts highlights functional differences , 2005, International journal of cancer.

[46]  J. Ladias,et al.  Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. , 2007, Journal of molecular biology.